Prostate cancer affects the prostate, a walnut-size gland in men that surrounds the urethra and normally helps produce seminal fluid. Unlike other cancer types, prostate cancer sometimes grows very slowly. If it's an early-stage cancer, it may be safe to use "watchful waiting" or "active surveillance" to monitor the cancer and delay treatment unless it gets bigger or more threatening. Prostate cancer treatments include radiation, surgery, and hormone therapy, which can have side effects such as erectile dysfunction or incontinence.
Prostate Cancer News
By Steven ReinbergHealthDay Reporter TUESDAY, Sept. 22, 2015 (HealthDay News) — Men with prostate cancer who also have had a heart attack may fare better with radiation therapy alone rather than with the standard treatment of radiation plus hormone therapy, a new analysis suggests. Over an average of 17 years of follow-up, men with high-risk prostate [...]
By Steven ReinbergHealthDay Reporter TUESDAY, Sept. 22, 2015 (HealthDay News) — Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then, PSA screening [...]
By Steven ReinbergHealthDay Reporter WEDNESDAY, Aug. 5, 2015 (HealthDay News) — Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost 14 months [...]
FRIDAY, July 17, 2015 (HealthDay News) — Higher doses of radiation may improve survival in men with medium- and high-risk prostate cancers, but it does not do the same for those with low-risk disease, a new study suggests. As is the case with many cancers, doctors must balance the risks and side effects of radiation therapy [...]
By Randy DotingaHealthDay Reporter TUESDAY, July 7, 2015 (HealthDay News) — More U.S. physicians are sparing their low-risk prostate cancer patients from surgery, radiation and hormone therapy in favor of monitoring their patients over time — a strategy called watchful waiting, a new study shows. The number of low-risk patients who didn’t undergo treatment jumped from as [...]